Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.78 |
| ▸ | HPGD | P15428 | 2/20 | 0.78 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.78 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.78 |
| ▸ | ABAT | P80404 | 1/20 | 0.78 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA3 | P07451 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | CA4 | P22748 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 2/20 | 0.59 |
| ▸ | CA5A | P35218 | 2/20 | 0.59 |
| ▸ | SNCA | P37840 | 2/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vanillin SCHEMBL28574264 | 0.91 | ALDH1A1 (0.78) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL29190533 | 0.91 | ALDH1A1 (0.78) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL11005312 | 0.90 | ALDH1A1 (0.89) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL27673973 | 0.90 | ALDH1A1 (0.89) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL29175199 | 0.90 | ALDH1A1 (0.96) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL891610 | 0.90 | ALDH1A1 (0.71) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL8992788 | 0.89 | ALDH1A1 (0.76) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL44060 | 0.89 | ALDH1A1 (0.86) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL15772747 | 0.89 | ALDH1A1 (0.86) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL81718 | 0.89 | ALDH1A1 (0.86) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | claimed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | claimed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | claimed |
| WO-2021071136-A2 | NOVEL PRESERVATIVE, AND METHOD FOR PRODUCING SAME | 동국대학교 산학협력단 | 2021-04-15 | — | — | WO | disclosed |
| CN-105814211-B | Method for producing single cell oil from lignocellulosic material | 耐思特公司 | 2020-11-06 | — | — | CN | disclosed |
| EP-2621462-B1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | PROCTER & GAMBLE (US) | 2020-02-12 | — | — | EP | disclosed |
| US-9937115-B2 | Oral care compositions with improved flavor | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-10 | — | — | US | disclosed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20130177688-A1 | Method of Flavoring | GIVAUDAN S.A. (CH) | 2013-07-11 | — | — | US | disclosed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | disclosed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | disclosed |
| EP-2237683-A2 | METHOD OF FLAVORING | Givaudan SA (CH) | 2010-10-13 | — | — | EP | disclosed |
| WO-2009092176-A2 | METHOD OF FLAVORING | GIVAUDAN SA (CH) | 2009-07-30 | — | — | WO | disclosed |
| US-20090186138-A1 | Method of Flavoring | GIVAUDAN SA (CH) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186138-A1 | Method of Flavoring | TAS2R5, TAS2R50, TAS2R10 | ALDH1A1 967/4885TDP1 4513/4885HPGD 956/4885 |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | ALDH1A1 1558/4885TDP1 3315/4885HPGD 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.